The SHOCKING Truth About Ozempic Side Effects (And How To Avoid Them)
What this video covers
This nearly two-hour episode stages a deliberate debate, with Hyman moderating two guests who hold sharply different views on GLP-1 drugs like Ozempic. Calley Means presents the “macro” critique: he argues that Big Pharma and a broken food system created the metabolic health crisis and are now positioning Ozempic as a lifelong, high-profit solution — including for children — which he calls a dangerous distraction from fixing the toxic food environment at the root.
Dr. Tyna Moore, a naturopathic physician focused on regenerative medicine, offers the contrasting “micro” view. She argues GLP-1 peptides have powerful regenerative and anti-inflammatory properties beyond weight loss, and describes her own approach of using low, physiologic doses from compounding pharmacies to help metabolically struggling patients — claiming this avoids the severe side effects seen with standard high-dose prescriptions.
Hyman positions the conversation as the nuanced middle ground the public debate lacks: not miracle drug, not pure disaster, but a complicated tool whose risks depend on dosing, context, and whether the underlying metabolic dysfunction is addressed. The discussion also touches on muscle loss, strength training, leptin and ghrelin interplay, and the lack of lifestyle-change support in mainstream healthcare.
Key points
- Calley Means argues Ozempic is being positioned as a lifelong, high-profit solution — including for children — by the same system that created the metabolic crisis.
- Means calls that approach a dangerous distraction from fixing the root cause: the toxic food environment.
- Dr. Tyna Moore counters that GLP-1 peptides have regenerative and anti-inflammatory properties extending beyond weight loss.
- Moore describes using low, physiologic doses from compounding pharmacies, which she claims avoids the severe side effects of standard high-dose prescriptions.
- Hyman frames the episode as a nuanced alternative to both “miracle drug” and “medical disaster” narratives.
- The conversation covers muscle loss risks, the interplay of leptin, ghrelin, and GLP-1, and dopamine/serotonin effects.
- Both guests criticize the healthcare system for offering drugs without accompanying lifestyle-change support.
- The episode reflects the MAHA movement’s internal tension: skepticism of pharma alongside openness to therapeutic tools used differently.